Discover how HZ-S109, a potent HPK1 degrader, revolutionizes cancer immunotherapy by supercharging T cells through targeted protein degradation.
Explore how pancreatic cancer manipulates lymphatic vessels and the immune system, and discover cutting-edge research models revealing new therapeutic pathways.
Discover how Rituximab triggers intracellular reorganization in B cells, creating a killing zone that enhances cancer cell destruction.
Discover how silencing the EPB41 gene transforms dendritic cells, enhancing their immune activation potential for advanced cancer therapies.
Exploring how integrin αvβ5 serves as a novel target for non-small cell lung cancer through tumor intrinsic and immune regulatory pathways
New research reveals how Natural Killer cells detach from tumor cells after delivering their lethal payload, enabling serial killing capabilities.